The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
A Recombinant Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Complex Stabilized by an Intermolecular Disulfide Bond between the gp120 and gp41 Subunits Is an Antigenic Mimic of the Trimeric Virion-Associated Structure
Open accessAbstract
The few antibodies that can potently neutralize human immunodeficiency virus type 1 (HIV-1) recognize the limited number of envelope glycoprotein epitopes exposed on infectious virions. These native envelope glycoprotein complexes comprise three gp120 subunits noncovalently and weakly associated with three gp41 moieties. The individual subunits induce neutralizing antibodies inefficiently but raise many nonneutralizing antibodies. Consequently, recombinant envelope glycoproteins do not elicit strong antiviral antibody responses, particularly against primary HIV-1 isolates. To try to develop recombinant proteins that are better antigenic mimics of the native envelope glycoprotein complex, we have introduced a disulfide bond between the C-terminal region of gp120 and the immunodominant segment of the gp41 ectodomain. The resulting gp140 protein is processed efficiently, producing a properly folded envelope glycoprotein complex. The association of gp120 with gp41 is now stabilized by the supplementary intermolecular disulfide bond, which forms with approximately 50% efficiency. The gp140 protein has antigenic properties which resemble those of the virion-associated complex. This type of gp140 protein may be worth evaluating for immunogenicity as a component of a multivalent HIV-1 vaccine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Fusion-Competent Vaccines: Broad Neutralization of Primary Isolates of HIV
LaCasse, R. A., Follis, K. E., Trahey, M., Scarborough, J. D., Littman, D. R., & Nunberg, J. H. (1999) · Science · doi:10.1126/science.283.5400.357 · Cited by 205
RetractedAntibodies, a laboratory manual
(1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90130-3 · Cited by 12,366
Kwong, P. D., Wyatt, R., Robinson, J., Sweet, R. W., Sodroski, J., & Hendrickson, W. A. (1998) · Nature · doi:10.1038/31405 · Cited by 2,964
Core Structure of gp41 from the HIV Envelope Glycoprotein
Chan, D. C., Fass, D., Berger, J. M., & Kim, P. S. (1997) · Cell · doi:10.1016/s0092-8674(00)80205-6 · Cited by 1,959
Atomic structure of the ectodomain from HIV-1 gp41
Weissenhorn, W., Dessen, A., Harrison, S. C., Skehel, J. J., & Wiley, D. C. (1997) · Nature · doi:10.1038/387426a0 · Cited by 1,622
The antigenic structure of the HIV gp120 envelope glycoprotein
Wyatt, R., Kwong, P. D., Desjardins, E., Sweet, R. W., Robinson, J., Hendrickson, W. A., & Sodroski, J. G. (1998) · Nature · doi:10.1038/31514 · Cited by 1,203
Trkola, A., Purtscher, M., Muster, T., Ballaun, C., Buchacher, A., Sullivan, N., Srinivasan, K., Sodroski, J., Moore, J. P., & Katinger, H. (1996) · Journal of Virology · doi:10.1128/jvi.70.2.1100-1108.1996 · Cited by 1,114
Self-citationEfficient Neutralization of Primary Isolates of HIV-1 by a Recombinant Human Monoclonal Antibody
Burton, D. R., Pyati, J., Koduri, R., Sharp, S. J., Thornton, G. B., Parren, P. W. H. I., Sawyer, L. S. W., Hendry, R. M., Dunlop, N., Nara, P. L., et al. (1994) · Science · doi:10.1126/science.7973652 · Cited by 1,100
Self-citationCD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5
Trkola, A., Dragic, T., Arthos, J., Binley, J. M., Olson, W. C., Allaway, G. P., Cheng-Mayer, C., Robinson, J., Maddon, P. J., & Moore, J. P. (1996) · Nature · doi:10.1038/384184a0 · Cited by 1,034
Self-citationLeonard, C. K., Spellman, M. W., Riddle, L., Harris, R. J., Thomas, J. N., & Gregory, T. J. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)86956-3 · Cited by 985
Dual Infection of the Central Nervous System by AIDS Viruses with Distinct Cellular Tropisms
Koyanagi, Y., Miles, S., Mitsuyasu, R. T., Merrill, J. E., Vinters, H. V., & Chen, I. S. Y. (1987) · Science · doi:10.1126/science.3646751 · Cited by 817
A Conserved HIV gp120 Glycoprotein Structure Involved in Chemokine Receptor Binding
Rizzuto, C. D., Wyatt, R., Hernández-Ramos, N., Sun, Y., Kwong, P. D., Hendrickson, W. A., & Sodroski, J. (1998) · Science · doi:10.1126/science.280.5371.1949 · Cited by 812
Thali, M., Moore, J. P., Furman, C., Charles, M., Ho, D. D., Robinson, J., & Sodroski, J. (1993) · Journal of Virology · doi:10.1128/jvi.67.7.3978-3988.1993 · Cited by 616
Self-citationEndoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus
McCune, J. M., Rabin, L. B., Feinberg, M. B., Lieberman, M., Kosek, J. C., Reyes, G. R., & Weissman, I. L. (1988) · Cell · doi:10.1016/0092-8674(88)90487-4 · Cited by 610
Sattentau, Q. J., & Moore, J. P. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.2.407 · Cited by 600
Self-citationInhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gpl60
Hallenberger, S., Bosch, V., Angliker, H., Shaw, E., Klenk, H.-D., & Garten, W. (1992) · Nature · doi:10.1038/360358a0 · Cited by 582
Dissociation of gp120 from HIV-1 Virions Induced by Soluble CD4
Moore, J. P., McKeating, J. A., Weiss, R. A., & Sattentau, Q. J. (1990) · Science · doi:10.1126/science.2251501 · Cited by 576
Self-citationA role for carbohydrates in immune evasion in AIDS
Reitter, J. N., Means, R. E., & Desrosiers, R. C. (1998) · Nature Medicine · doi:10.1038/nm0698-679 · Cited by 558
BUCHACHER, A., PREDL, R., STRUTZENBERGER, K., STEINFELLNER, W., TRKOLA, A., PURTSCHER, M., GRUBER, G., TAUER, C., STEINDL, F., JUNGBAUER, A., et al. (1994) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1994.10.359 · Cited by 529
Processing of the Ebola virus glycoprotein by the proprotein convertase furin
Volchkov, V. E., Feldmann, H., Volchkova, V. A., & Klenk, H.-D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.10.5762 · Cited by 497
Molloy, S. S., Thomas, L., VanSlyke, J. K., Stenberg, P. E., & Thomas, G. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06231.x · Cited by 487
Trkola, A., Pomales, A. B., Yuan, H., Korber, B., Maddon, P. J., Allaway, G. P., Katinger, H., Barbas, C. F., Burton, D. R., & Ho, D. D. (1995) · Journal of Virology · doi:10.1128/jvi.69.11.6609-6617.1995 · Cited by 480
Self-citationRoben, P., Moore, J. P., Thali, M., Sodroski, J., Barbas, C. F., & Burton, D. R. (1994) · Journal of Virology · doi:10.1128/jvi.68.8.4821-4828.1994 · Cited by 455
Self-citationFolding and Assembly of Viral Membrane Proteins
Doms, R. W., Lamb, R. A., Rose, J. K., & Helenius, A. (1993) · Virology · doi:10.1006/viro.1993.1164 · Cited by 442
Mascola, J. R., Snyder, S. W., Weislow, O. S., Belay, S. M., Belshe, R. B., Schwartz, D. H., Clements, M. L., Dolin, R., Graham, B. S., Gorse, G. J., et al. (1996) · Journal of Infectious Diseases · doi:10.1093/infdis/173.2.340 · Cited by 436
Willey, R. L., Bonifacino, J. S., Potts, B. J., Martin, M. A., & Klausner, R. D. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.24.9580 · Cited by 428
Wyatt, R., Moore, J., Accola, M., Desjardin, E., Robinson, J., & Sodroski, J. (1995) · Journal of Virology · doi:10.1128/jvi.69.9.5723-5733.1995 · Cited by 417
Self-citationToward an Understanding of the Correlates of Protective Immunity to HIV Infection
Haynes, B. F., Pantaleo, G., & Fauci, A. S. (1996) · Science · doi:10.1126/science.271.5247.324 · Cited by 413
Three-dimensional solution structure of the 44kDa ectodomain of SIV gp41
Caffrey, M. (1998) · The EMBO Journal · doi:10.1093/emboj/17.16.4572 · Cited by 410
Moore, J. P., Cao, Y., Qing, L., Sattentau, Q. J., Pyati, J., Koduri, R., Robinson, J., Barbas, C. F., Burton, D. R., & Ho, D. D. (1995) · Journal of Virology · doi:10.1128/jvi.69.1.101-109.1995 · Cited by 401
Self-citationWeissenhorn, W., Carfí, A., Lee, K.-H., Skehel, J. J., & Wiley, D. C. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80159-8 · Cited by 391
Oligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein.
Earl, P. L., Doms, R. W., & Moss, B. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.2.648 · Cited by 359
Collman, R., Balliet, J. W., Gregory, S. A., Friedman, H., Kolson, D. L., Nathanson, N., & Srinivasan, A. (1992) · Journal of Virology · doi:10.1128/jvi.66.12.7517-7521.1992 · Cited by 358
Complete Nucleotide Sequences of Functional Clones of the AIDS Virus
RATNER, L., FISHER, A., JAGODZINSKI, L. L., MITSUYA, H., LIOU, R.-S., GALLO, R. C., & WONG-STAAL, F. (1987) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1987.3.57 · Cited by 341
Sattentau, Q. J., & Moore, J. P. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.1.185 · Cited by 334
Self-citationSattentau, Q. J., Moore, J. P., Vignaux, F., Traincard, F., & Poignard, P. (1993) · Journal of Virology · doi:10.1128/jvi.67.12.7383-7393.1993 · Cited by 317
Self-citationRetrovirus envelope domain at 1.7 Å resolution
Fass, D., Harrison, S. C., & Kim, P. S. (1996) · Nature Structural Biology · doi:10.1038/nsb0596-465 · Cited by 314
Moore, J. P., & Sodroski, J. (1996) · Journal of Virology · doi:10.1128/jvi.70.3.1863-1872.1996 · Cited by 304
Self-citationSullivan, N., Sun, Y., Sattentau, Q., Thali, M., Wu, D., Denisova, G., Gershoni, J., Robinson, J., Moore, J., & Sodroski, J. (1998) · Journal of Virology · doi:10.1128/jvi.72.6.4694-4703.1998 · Cited by 292
Self-citationHelseth, E., Olshevsky, U., Furman, C., & Sodroski, J. (1991) · Journal of Virology · doi:10.1128/jvi.65.4.2119-2123.1991 · Cited by 292
Sullivan, N., Sun, Y., Li, J., Hofmann, W., & Sodroski, J. (1995) · Journal of Virology · doi:10.1128/jvi.69.7.4413-4422.1995 · Cited by 292
Muster, T., Guinea, R., Trkola, A., Purtscher, M., Klima, A., Steindl, F., Palese, P., & Katinger, H. (1994) · Journal of Virology · doi:10.1128/jvi.68.6.4031-4034.1994 · Cited by 286
Stable exposure of the coreceptor-binding site in a CD4-independent HIV-1 envelope protein
Hoffman, T. L., LaBranche, C. C., Zhang, W., Canziani, G., Robinson, J., Chaiken, I., Hoxie, J. A., & Doms, R. W. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6359 · Cited by 263
Retrovirus Envelope Glycoproteins
Hunter, E., & Swanstrom, R. (1990) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-75218-6_7 · Cited by 262
Core structure of the envelope glycoprotein GP2 from Ebola virus at 1.9-Å resolution
Malashkevich, V. N., Schneider, B. J., McNally, M. L., Milhollen, M. A., Pang, J. X., & Kim, P. S. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.2662 · Cited by 261
Progress in the Development of an HIV-1 Vaccine
Letvin, N. L. (1998) · Science · doi:10.1126/science.280.5371.1875 · Cited by 253
The neutralizing antibody response to HIV-1: viral evasion and escape from humoral immunity.
Parren, P. W. H. I., Moore, J. P., Burton, D. R., & Sattentau, Q. J. (1999) · PubMed · Cited by 248
Self-citationMoore, J. P., Sattentau, Q. J., Wyatt, R., & Sodroski, J. (1994) · Journal of Virology · doi:10.1128/jvi.68.1.469-484.1994 · Cited by 248
Self-citationEarl, P. L., Koenig, S., & Moss, B. (1991) · Journal of Virology · doi:10.1128/jvi.65.1.31-41.1991 · Cited by 229
McKeating, J. A., McKnight, A., & Moore, J. P. (1991) · Journal of Virology · doi:10.1128/jvi.65.2.852-860.1991 · Cited by 224
Self-citationCao, J., Bergeron, L., Helseth, E., Thali, M., Repke, H., & Sodroski, J. (1993) · Journal of Virology · doi:10.1128/jvi.67.5.2747-2755.1993 · Cited by 223
Cao, J., Sullivan, N., Desjardin, E., Parolin, C., Robinson, J., Wyatt, R., & Sodroski, J. (1997) · Journal of Virology · doi:10.1128/jvi.71.12.9808-9812.1997 · Cited by 219
Earl, P. L., Broder, C. C., Long, D., Lee, S. A., Peterson, J., Chakrabarti, S., Doms, R. W., & Moss, B. (1994) · Journal of Virology · doi:10.1128/jvi.68.5.3015-3026.1994 · Cited by 215
A vaccine for HIV type 1: The antibody perspective
Burton, D. R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.19.10018 · Cited by 207
Connor, R. I., Korber, B. T. M., Graham, B. S., Hahn, B. H., Ho, D. D., Walker, B. D., Neumann, A. U., Vermund, S. H., Mestecky, J., Jackson, S., et al. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.1552-1576.1998 · Cited by 203
Self-citationBinley, J. M., Klasse, P. J., Cao, Y., Jones, I., Markowitz, M., Ho, D. D., & Moore, J. P. (1997) · Journal of Virology · doi:10.1128/jvi.71.4.2799-2809.1997 · Cited by 176
Self-citationABACIOGLU, Y. H., FOUTS, T. R., LAMAN, J. D., CLAASSEN, E., PINCUS, S. H., MOORE, J. P., ROBY, C. A., KAMIN-LEWIS, R., & LEWIS, G. K. (1994) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1994.10.371 · Cited by 176
Self-citationGodley, L., Pfeifer, J., Steinhauer, D., Ely, B., Shaw, G., Kaufmann, R., Suchanek, E., Pabo, C., Skehel, J. J., Wiley, D. C., et al. (1992) · Cell · doi:10.1016/0092-8674(92)90140-8 · Cited by 175
HIV-1 neutralization: the consequences of viral adaptation to growth on transformed T cells.
Jp, M., & Ho, D. D. (1995) · PubMed · Cited by 171
Zhou, N. E., Kay, C. M., & Hodges, R. S. (1993) · Biochemistry · doi:10.1021/bi00063a033 · Cited by 169
Trkola, A., Ketas, T., KewalRamani, V. N., Endorf, F., Binley, J. M., Katinger, H., Robinson, J., Littman, D. R., & Moore, J. P. (1998) · Journal of Virology · doi:10.1128/jvi.72.3.1876-1885.1998 · Cited by 160
Self-citationTakeuchi, Y., Akutsu, M., Murayama, K., Shimizu, N., & Hoshino, H. (1991) · Journal of Virology · doi:10.1128/jvi.65.4.1710-1718.1991 · Cited by 155
HIV-1 antibody — debris or virion?
Parren, P. W. H. I., Burton, D. R., & Sattentau, Q. J. (1997) · Nature Medicine · doi:10.1038/nm0497-366d · Cited by 153
Pinter, A., Kopelman, R., Li, Z., Kayman, S. C., & Sanders, D. A. R. (1997) · Journal of Virology · doi:10.1128/jvi.71.10.8073-8077.1997 · Cited by 151
Barnett, S. W. (1997) · Vaccine · doi:10.1016/s0264-410x(96)00264-2 · Cited by 146
Similar Structural Models of the Transmembrane Proteins of Ebola and Avian Sarcoma Viruses
Gallaher, W. R. (1996) · Cell · doi:10.1016/s0092-8674(00)81248-9 · Cited by 137
The antibody response in HIV-1 infection.
Burton, D. R., & Montefiori, D. C. (1997) · PubMed · Cited by 125
Rowland‐Jones, S., Tan, R., & McMichael, A. J. (1997) · Advances in immunology · doi:10.1016/s0065-2776(08)60745-2 · Cited by 123
LOSS OF ENVELOPE ANTIGENS OF HTLV-III/LAV, A FACTOR IN AIDS PATHOGENESIS?
Gelderblom, H., Reupke, H., & Pauli, G. (1985) · The Lancet · doi:10.1016/s0140-6736(85)90570-7 · Cited by 118
Moore, J. P., McKeating, J. A., Jones, I. M., Stephens, P. E., Clements, G., Thomson, S., & Weiss, R. A. (1990) · AIDS · doi:10.1097/00002030-199004000-00004 · Cited by 116
Self-citationSubunit structure of the glycoprotein complex of avian tumor virus
Leamnson, R. N., & Halpern, M. S. (1976) · Journal of Virology · doi:10.1128/jvi.18.3.956-968.1976 · Cited by 107
A General Model for the Surface Glycoproteins of HIV and Other Retroviruses
Gallaher, W. R., Ball, J. M., Garry, R. F., MARTIN-AMEDEE, A. M., & Montelaro, R. C. (1995) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1995.11.191 · Cited by 104
Wyatt, R. T., Desjardin, E., Olshevsky, U., Nixon, C., Binley, J. Μ., Olshevsky, V., & Sodroski, J. (1997) · Journal of Virology · doi:10.1128/jvi.71.12.9722-9731.1997 · Cited by 97
Self-citationBerman, P. W., Nunes, W. M., & Haffar, O. K. (1988) · Journal of Virology · doi:10.1128/jvi.62.9.3135-3142.1988 · Cited by 95
Schulz, T. F., Jameson, B. A., Lopalco, L., Siccardi, A. G., Weiss, R. A., & Moore, J. P. (1992) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1992.8.1571 · Cited by 89
Self-citationWhite‐Scharf, M. E., Potts, B. J., Taylor-Smith, L. M., Sokolowski, K. A., Rusche, J. R., & Silver, S. (1993) · Virology · doi:10.1006/viro.1993.1022 · Cited by 88
Moore, J. P., Willey, R. L., Lewis, G. K., Robinson, J., & Sodroski, J. (1994) · Journal of Virology · doi:10.1128/jvi.68.11.6836-6847.1994 · Cited by 86
Self-citationPique, C., Pham, D., Tursz, T., & Dokhélar, M. (1992) · Journal of Virology · doi:10.1128/jvi.66.2.906-913.1992 · Cited by 82
Graham, B. S., McElrath, M. J., Connor, R. I., et al. (1998) · The Journal of Infectious Diseases · doi:10.1086/514209 · Cited by 81
Dubay, J. W., Dubay, S. R., Shin, H., & Hunter, E. (1995) · Journal of Virology · doi:10.1128/jvi.69.8.4675-4682.1995 · Cited by 79
Farzan, M., Choe, H., Desjardins, E., Sun, Y., Kuhn, J. H., Cao, J., Archambault, D., Kolchinsky, P., Koch, M., Wyatt, R. T., et al. (1998) · Journal of Virology · doi:10.1128/jvi.72.9.7620-7625.1998 · Cited by 77
Otteken, A., Earl, P. L., & Moss, B. (1996) · Journal of Virology · doi:10.1128/jvi.70.6.3407-3415.1996 · Cited by 75
Baldinotti, F., Matteucci, D., Mazzetti, P., Giannelli, C., Bandecchi, P., Tozzini, F., & Bendinelli, M. (1994) · Journal of Virology · doi:10.1128/jvi.68.7.4572-4579.1994 · Cited by 74
Humoral response to oligomeric human immunodeficiency virus type 1 envelope protein
Richardson, T. M., Stryjewski, B. L., Broder, C. C., Hoxie, J. A., Mascola, J. R., Earl, P. L., & Doms, R. W. (1996) · Journal of Virology · doi:10.1128/jvi.70.2.753-762.1996 · Cited by 72
The prime-boost concept applied to HIV preventive vaccines.
Jl, E., & Plotkin, S. A. (1997) · PubMed · Cited by 67
Binley, J. Μ., & Moore, J. P. (1997) · Nature · doi:10.1038/387346a0 · Cited by 65
Self-citationLegitimate and illegitimate cleavage of human immunodeficiency virus glycoproteins by furin
Morikawa, Y., Barsov, E. V., & Jones, I. M. (1993) · Journal of Virology · doi:10.1128/jvi.67.6.3601-3604.1993 · Cited by 59
Opstelten, D.-J. E., Wallin, M., & Garoff, H. (1998) · Journal of Virology · doi:10.1128/jvi.72.8.6537-6545.1998 · Cited by 58
Chen, S. S. (1994) · Journal of Virology · doi:10.1128/jvi.68.3.2002-2010.1994 · Cited by 56
Binley, J. Μ., Wyatt, R. T., Desjardins, E., Kwong, P. D., Hendrickson, W. A., Moore, J. P., & Sodroski, J. (1998) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1998.14.191 · Cited by 53
Self-citationTrimerization Specificity in HIV-1 gp41: Analysis with a GCN4 Leucine Zipper Model,
Shu, W., Ji, H., & Lu, M. (1999) · Biochemistry · doi:10.1021/bi990199w · Cited by 50
Similarities among retrovirus proteins
Patarca, R., & Haseltine, W. A. (1984) · Nature · doi:10.1038/312496a0 · Cited by 41
Veronese, F. D. M., Rahman, R., Pal, R., Boyer-Thompson, C., Romano, J., Kalyanaraman, V. S., Nair, B. C., Gallo, R. C., & Sarngadharan, M. G. (1992) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1992.8.1125 · Cited by 20
Peng, H., Callison, D. E., Li, P., & Burrell, C. J. (1997) · AIDS · doi:10.1097/00002030-199705000-00006 · Cited by 17
Cited by
Mechanisms of Viral Membrane Fusion and Its Inhibition
Eckert, D. M., & Kim, P. S. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.777 · Cited by 1,282
Li, M., Gao, F., Mascola, J. R., Stamatatos, L., Polonis, V. R., Koutsoukos, M., Voss, G., Goepfert, P., Gilbert, P., Greene, K. M., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.16.10108-10125.2005 · Cited by 1,070
Sanders, R. W., Derking, R., Cupo, A., Julien, J.-P., Yasmeen, A., de Val, N., Kim, H. J., Blattner, C., de la Peña, A. T., Korzun, J., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003618 · Cited by 935
Self-citationDiversity Considerations in HIV-1 Vaccine Selection
Gaschen, B., Taylor, J., Yusim, K., Foley, B., Gao, F., Lang, D., Novitsky, V., Haynes, B., Hahn, B. H., Bhattacharya, T., et al. (2002) · Science · doi:10.1126/science.1070441 · Cited by 811
Crystal Structure of a Soluble Cleaved HIV-1 Envelope Trimer
Julien, J.-P., Cupo, A., Sok, D., Stanfield, R. L., Lyumkis, D., Deller, M. C., Klasse, P.-J., Burton, D. R., Sanders, R. W., Moore, J. P., et al. (2013) · Science · doi:10.1126/science.1245625 · Cited by 797
Self-citation
Metadata
- Authors
- Binley, J. M., Sanders, R. W., Clas, B., Schuelke, N., Master, A., Guo, Y., Kajumo, F., Anselma, D. J., Maddon, P. J., Olson, W. C., & Moore, J. P.
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2000-01-15
- Volume
- 74
- Issue
- 2
- Pages
- 627-643
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- OpenAlex
- W2129274180
- Cited by
- 534
- References
- 94
- FWCI
- 9.34
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.